重藥控股(000950.SZ)擬收購天士營銷及陝西天士力物流
格隆匯12月16日丨重藥控股(000950.SZ)公佈,公司控股子公司重慶醫藥(集團)股份有限公司(“重慶醫藥”)與天士力醫藥集團股份有限公司(“天士力”)等8位交易對方簽署了《關於收購天津天士力醫藥營銷集團股份有限公司及陝西天士力醫藥物流有限公司股權的框架協議》,該協議僅為雙方對資產交易事項的初步意向,並非最終交易方案,具體交易方案仍需要進一步論證和溝通協商。
根據《框架協議》,在天津天士力醫藥營銷集團股份有限公司(“天士營銷”)完成相關業務剝離的前提下,重慶醫藥擬通過支付現金對價的方式收購天士營銷98.32%股權;因目前天士營銷正在進行摘牌,天士營銷摘牌完成後將由天士力對其他股東進行股份回購,天士力在客觀條件許可的情況下將全部回購。天士力回購完成後,重慶醫藥將購買其所回購天士營銷全部股權。
另外,重慶醫藥將購買天士力控股持有的陝西天士力醫藥物流有限公司(“陝西天士力物流”)100%股權。
天士營銷主要負責天士力的醫藥商業業務板塊,陝西天士力物流是一家專業的醫藥三方物流公司,為醫藥健康產業供應鏈上下游提供專業三方物流服務;通過此次資產收購,公司將有效拓展銷售區域,加快公司推進全國性網絡佈局的步伐,為公司實現“走向全國”的戰略目標打下堅實基礎。同時,公司擬通過此次交易與天士力在醫藥商業領域建立長期良好的合作關係,最終實現合作共贏的戰略目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.